Comparison of BiPAP and ٰIS in Reducing Post CABG Pulmonary Complications
NCT ID: NCT04700215
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
350 participants
INTERVENTIONAL
2021-03-01
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema
NCT00213681
Incentive Spirometer in Liver Transplant Recipients
NCT07318766
The Effect of Acapella and Incentive Spirometry on Blood Gases and Peak Expiratory Flow Rate After Coronary Artery Bypass Graft.
NCT07337746
Non Invasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema
NCT00912158
Focused Incentive Spirometry Monitoring to Reduce Postoperative Oxygen Therapy and Respiratory Complications After Bariatric Surgery
NCT03010852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This Randomized Controlled Trial (RCT) study will be conducted at Chaudhary pervaiz elahi institute of cardiology ICU multan.
A sample size of 350 patients will be taken and effect of BiPAP and Incentive spirometry will be studied in reducing pulmonary complications post CABG surgery. Data will be analyzed through SPSS. For quantitative variables, mean and standard deviation will be calculated and for qualitative variables, frequency and percentage will be calculated. Chi square test will be used to estimate association between qualitative variables. A p value \< 0.05 will be significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 01 Effectiveness of BiPAP in reducing post CABG pulmonary complications
Bilevel positive airway pressure device after every 6 hours
BiPAP
To give bilevel positive airway pressure to the lungs
Group 02 Effectiveness of IS in reducing post CABG pulmonary complications
Incentive spirometry for 15 minutes after every 4 hours
Incentive spirometry
IS for 15 minutes after every 4 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BiPAP
To give bilevel positive airway pressure to the lungs
Incentive spirometry
IS for 15 minutes after every 4 hours
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient willing to study
* Patients planned for on-pump cardiac surgical procedures
* Both genders (Male \& Female)
* Age 20-60 years
* Ejection fraction 40-60%
Exclusion Criteria
* Off-pump cardiac surgery
* Refusal to give consent for BiPAP
* Emergency surgery
* Previous cardiac surgery
* Obesity BMI\>30
* ASA status V
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chaudhry Pervaiz Elahi Institute of Cardiology
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Imran Khan
Doctor Muhammad Imran Khan
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad Imran Khan, MBBS
Role: PRINCIPAL_INVESTIGATOR
Chaudhry Pervaiz Elahi Institute of Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CPEIC
Multan Khurd, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No.01-2020/ED/CPEIC/MULTAN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.